ArticleOncoimmunology2021

LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells.

Takahiro Yamazaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.